Endocrinology Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Endocrinology Tests Pipeline Market Report Overview

Endocrinology tests are the reagents used for quantification and detection of endocrine hormones secreted in the human body. The endocrinology tests pipeline market research report provides comprehensive information about the endocrinology tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Segments ·        Growth Hormone (GH) Function Tests

·        Individual and Specified Hormones

·        Bone Metabolism Assays

·        Adrenocorticotropic Hormone (ACTH) Function Tests

·        25-OH Vitamin D Tests

·        Parathyroid Hormone (PTH) Tests

·        Calcitonin Tests

Key Territories ·        The United States

·        China

·        Europe

·        Australia

·        Singapore

·        India

·        Japan

·        South Korea

Key Regulatory Paths ·        510(k)

·        NMPA

·        CE-IVD

·        TGA

·        HSA

·        ICAC

·        Ninsho

·        MDITAC

·        CLIA

·        BLA

·        CE

Leading Companies ·        AMS Diagnostics LLC

·        Beckman Coulter Inc

·        Celmatix Inc

·        Denka Seiken Co Ltd

·        DiaSorin SpA

·        EDP Biotech Corporation

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Endocrinology Tests Pipeline Market by Segments

The key segments in the endocrinology tests pipeline market are Growth Hormone (GH) Function Tests, Individual and Specified Hormones, Bone Metabolism Assays, Adrenocorticotropic Hormone (ACTH) Function Tests, 25-OH Vitamin D Tests, Parathyroid Hormone (PTH) Tests, and Calcitonin Tests. As of September 2023, Growth Hormone (GH) Function Tests have a higher number of pipeline products.

Endocrinology Tests Pipeline Market Analysis by Segments, 2023 (%)

Endocrinology Tests Pipeline Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment Insights into the Endocrinology tests Pipeline Market

Download A Free Report Sample

Endocrinology Tests Pipeline Market Segmentation by Territories

Some of the key territories in the endocrinology tests market are the United States, China, Europe, Australia, Singapore, India, Japan, and South Korea. As of September 2023, the global market besides the above-mentioned countries has the highest number of pipeline products.

Endocrinology Tests Pipeline Market Analysis by Territories, 2023 (%)

Endocrinology Tests Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Endocrinology Tests Pipeline Market

Download A Free Report Sample

Endocrinology Tests Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the endocrinology tests pipeline market are 510(k), NMPA, CE-IVD, TGA, HSA, ICAC, Ninsho, MDITAC, CLIA, BLA, and CE. As of September 2023, 510(k) is the most followed pathway for pipeline products in the market.

Endocrinology Tests Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Endocrinology Tests Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Endocrinology Tests Pipeline Market
Download A Free Report Sample

Endocrinology Tests Pipeline Market – Competitive Landscape

Some of the key companies in the endocrinology tests pipeline market are AMS Diagnostics LLC, Beckman Coulter Inc, Celmatix Inc, Columbia University, Denka Seiken Co Ltd, DiaSorin SpA, and DIANA Biotechnologies SRO among others.

Celmatix Inc: Celmatix Inc (Celmatix) discovers and develops women’s health therapeutics. The company’s lead program ovarian senescence provides chemotherapy-induced ovarian failure for women with mosaic turner syndrome, primary ovarian insufficiency, endometriosis, and polycystic ovary syndrome.

DiaSorin SpA: DiaSorin SpA (DiaSorin) is a medical diagnostics company that is engaged in the development, manufacturing, and marketing of in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Enzyme-Linked Immunosorbent Assays (ELISA) and Chemiluminescence (CLIA) techniques, to enable automatic diagnostic investigation.

Endocrinology Tests Pipeline Market Analysis by Companies, 2023

Endocrinology Tests Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Endocrinology Tests Pipeline Market
Download A Free Report Sample

Segments Covered in the Report

Endocrinology Tests Pipeline Market Segments Outlook

  • Growth Hormone (GH) Function Tests
  • Individual and Specified Hormones
  • Bone Metabolism Assays
  • Adrenocorticotropic Hormone (ACTH) Function Tests
  • 25-OH Vitamin D Tests
  • Parathyroid Hormone (PTH) Tests
  • Calcitonin Tests

Endocrinology Tests Pipeline Market Territories Outlook

  • The United States
  • China
  • Europe
  • Australia
  • Singapore
  • India
  • Japan
  • South Korea

Endocrinology Tests Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • NMPA
  • CE-IVD
  • TGA
  • HSA
  • ICAC
  • Ninsho
  • MDITAC
  • CLIA
  • BLA
  • CE

Scope

This report provides:

  • Extensive coverage of the endocrinology tests under development.
  • Details of major pipeline products which include product description, licensing and collaboration details and other developmental activities.
  • Reviews of major players involved in the development of endocrinology tests and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Provides key clinical trial data related to ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of endocrinology tests under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Albert Einstein College of Medicine
AMS Diagnostics LLC
Axis-Shield Diagnostics Ltd
Beckman Coulter Inc
Carolina Liquid Chemistries Corp
Celmatix Inc
Ceres Nanosciences Inc
Columbia University
Denka Seiken Co Ltd
DIANA Biotechnologies SRO
DiaSorin SpA
EDP Biotech Corporation
G Medical Health and Wellness
Guangzhou Wondfo Biotech Co Ltd
Hansjorg Wyss Institute for Biologically Inspired Engineering
I-Mab Biopharma Co Ltd
Intelligent Bio Solutions Inc
Laboratoire HRA Pharma SAS
MDNA Life Sciences Inc
MyHealthTest Pty Ltd
Revvity Inc
Roche Diagnostics International Ltd
Sendera Discovery
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Siemens Healthcare Diagnostics Inc
Solvd Health
Thermo Fisher Scientific Inc
Tosoh Bioscience Inc
University of California San Francisco

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 9

2 Introduction 10

2.1 Endocrinology Tests Overview 10

3 Products under Development 11

3.1 Endocrinology Tests – Pipeline Products by Stage of Development 11

3.2 Endocrinology Tests – Pipeline Products by Segment 12

3.3 Endocrinology Tests – Pipeline Products by Territory 13

3.4 Endocrinology Tests – Pipeline Products by Regulatory Path 14

3.5 Endocrinology Tests – Pipeline Products by Estimated Approval Date 15

4 Endocrinology Tests – Pipeline Products under Development by Companies 16

4.1 Endocrinology Tests Companies – Pipeline Products by Stage of Development 16

4.2 Endocrinology Tests – Pipeline Products by Stage of Development 18

5 Endocrinology Tests Companies and Product Overview 20

5.1 Albert Einstein College of Medicine Company Overview 20

5.1.1 Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 20

5.2 AMS Diagnostics LLC Company Overview 22

5.2.1 AMS Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 22

5.3 Axis-Shield Diagnostics Ltd Company Overview 23

5.3.1 Axis-Shield Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

5.4 Beckman Coulter Inc Company Overview 24

5.4.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 24

5.5 Carolina Liquid Chemistries Corp Company Overview 25

5.5.1 Carolina Liquid Chemistries Corp Pipeline Products & Ongoing Clinical Trials Overview 25

5.6 Celmatix Inc Company Overview 26

5.6.1 Celmatix Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.7 Ceres Nanosciences Inc Company Overview 27

5.7.1 Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 27

5.8 Columbia University Company Overview 28

5.8.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 28

5.9 Denka Seiken Co Ltd Company Overview 29

5.9.1 Denka Seiken Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

5.10 DIANA Biotechnologies SRO Company Overview 30

5.10.1 DIANA Biotechnologies SRO Pipeline Products & Ongoing Clinical Trials Overview 30

5.11 DiaSorin SpA Company Overview 31

5.11.1 DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 31

5.12 EDP Biotech Corporation Company Overview 34

5.12.1 EDP Biotech Corporation Pipeline Products & Ongoing Clinical Trials Overview 34

5.13 G Medical Health and Wellness Company Overview 35

5.13.1 G Medical Health and Wellness Pipeline Products & Ongoing Clinical Trials Overview 35

5.14 Guangzhou Wondfo Biotech Co Ltd Company Overview 38

5.14.1 Guangzhou Wondfo Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 38

5.15 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview 42

5.15.1 Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview 42

5.16 I-Mab Biopharma Co Ltd Company Overview 43

5.16.1 I-Mab Biopharma Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 43

5.17 Intelligent Bio Solutions Inc Company Overview 44

5.17.1 Intelligent Bio Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 44

5.18 Laboratoire HRA Pharma SAS Company Overview 48

5.18.1 Laboratoire HRA Pharma SAS Pipeline Products & Ongoing Clinical Trials Overview 48

5.19 MDNA Life Sciences Inc Company Overview 49

5.19.1 MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 49

5.20 MyHealthTest Pty Ltd Company Overview 50

5.20.1 MyHealthTest Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

5.21 Revvity Inc Company Overview 51

5.21.1 Revvity Inc Pipeline Products & Ongoing Clinical Trials Overview 51

5.22 Roche Diagnostics International Ltd Company Overview 52

5.22.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

5.23 Sendera Discovery Company Overview 59

5.23.1 Sendera Discovery Pipeline Products & Ongoing Clinical Trials Overview 59

5.24 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview 60

5.24.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

5.25 Siemens Healthcare Diagnostics Inc Company Overview 64

5.25.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 64

5.26 Solvd Health Company Overview 78

5.26.1 Solvd Health Pipeline Products & Ongoing Clinical Trials Overview 78

5.27 Thermo Fisher Scientific Inc Company Overview 79

5.27.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 79

5.28 Tosoh Bioscience Inc Company Overview 80

5.28.1 Tosoh Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 80

5.29 University of California San Francisco Company Overview 81

5.29.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 81

6 Endocrinology Tests- Recent Developments 82

6.1 Aug 31, 2023: Integrated Diagnostics Holdings Announces Half Year Report 82

6.2 Jun 12, 2023: Abbott Names Philip Boudreau CFO effective Sept. 1 84

6.3 Jun 07, 2023: Eckert & Ziegler Strahlen Annual General Meeting Approves Dividend of EUR

0.50 per Share 84

6.4 Jun 01, 2023: Integrated Diagnostics announces Q1 2023 Results 85

6.5 Apr 06, 2023: Integrated Diagnostics Holdings Announces Final Results 86

6.6 Apr 06, 2023: Integrated Diagnostics Holdings concludes 2022 reporting solid 18% growth in non-Covid revenues 88

6.7 Feb 22, 2023: Novo Nordisk Notice for the Annual General Meeting 91

6.8 Dec 20, 2022: Eckert & Ziegler Announces Changes in the Supervisory Board 92

6.9 Dec 19, 2022: Eckert & Ziegler Announces Changes in the Management Board 92

6.10 Nov 17, 2022: Integrated Diagnostics Holdings 3rd Quarter Results 92

6.11 Oct 31, 2022: IDH and its Jordanian subsidiary, Biolab, to Launch Greenfield Diagnostic Venture in Saudi Arabia in Partnership with Izhoor Medical, a company owned by Fawaz Alhokair 95

6.12 Oct 05, 2022: DiaSorin Gets $31M BARDA Funding for Point-of-Care Instrument 97

7 Appendix 98

7.1 Methodology 98

7.2 About GlobalData 101

7.3 Contact Us 101

7.4 Disclaimer 101

Table

Endocrinology Tests – Pipeline Products by Stage of Development 11

Endocrinology Tests – Pipeline Products by Segment 12

Endocrinology Tests – Pipeline Products by Territory 13

Endocrinology Tests – Pipeline Products by Regulatory Path 14

Endocrinology Tests – Pipeline Products by Estimated Approval Date 15

Endocrinology Tests Companies – Pipeline Products by Stage of Development 16

Endocrinology Tests – Pipeline Products by Stage of Development 18

Albert Einstein College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 20

Cortisol Assay – Product Status 20

Cortisol Assay – Product Description 20

Progesterone Assay – Product Status 21

Progesterone Assay – Product Description 21

AMS Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 22

Liasys 450 – Vitamin D Assay – Product Status 22

Liasys 450 – Vitamin D Assay – Product Description 22

Axis-Shield Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

Vitamin D Assay – Product Status 23

Vitamin D Assay – Product Description 23

Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 24

UniCel PlGF Assay – Product Status 24

UniCel PlGF Assay – Product Description 24

Carolina Liquid Chemistries Corp Pipeline Products & Ongoing Clinical Trials Overview 25

CLC 480 Analyzer – Vitamin D Assay – Product Status 25

CLC 480 Analyzer – Vitamin D Assay – Product Description 25

Celmatix Inc Pipeline Products & Ongoing Clinical Trials Overview 26

FertilArray – Product Status 26

FertilArray – Product Description 26

Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 27

Nanotrap HGH Test – Product Status 27

Nanotrap HGH Test – Product Description 27

Columbia University Pipeline Products & Ongoing Clinical Trials Overview 28

Diagnostic Test – Menopause – Product Status 28

Diagnostic Test – Menopause – Product Description 28

Denka Seiken Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

Adiponectin Assay Kit – Product Status 29

Adiponectin Assay Kit – Product Description 29

DIANA Biotechnologies SRO Pipeline Products & Ongoing Clinical Trials Overview 30

DIANA Assay – Insulin-like Growth Factor Receptor – Product Status 30

DIANA Assay – Insulin-like Growth Factor Receptor – Product Description 30

DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 31

LIAISON – High Sclerostin Assay – Product Status 31

LIAISON – High Sclerostin Assay – Product Description 32

LIAISON – Hyperphosphate High Bone Turnover Assay – Product Status 32

LIAISON – Hyperphosphate High Bone Turnover Assay – Product Description 32

LIAISON – Hyperphosphate Low Bone Turnover Assay – Product Status 33

LIAISON – Hyperphosphate Low Bone Turnover Assay – Product Description 33

EDP Biotech Corporation Pipeline Products & Ongoing Clinical Trials Overview 34

Diagnostic Assay – Early Conception Factor – Product Status 34

Diagnostic Assay – Early Conception Factor – Product Description 34

G Medical Health and Wellness Pipeline Products & Ongoing Clinical Trials Overview 35

Perimenopause Test – Product Status 35

Perimenopause Test – Product Description 35

Sleep and Stress Test – Product Status 36

Sleep and Stress Test – Product Description 36

Weight Loss Test – Product Status 36

Weight Loss Test – Product Description 37

Guangzhou Wondfo Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 38

Accre Diagnostic Assay – ACTH – Product Status 38

Accre Diagnostic Assay – ACTH – Product Description 39

Accre Diagnostic Assay – DHEA-S – Product Status 39

Accre Diagnostic Assay – DHEA-S – Product Description 39

Accre Diagnostic Assay – hGH – Product Status 40

Accre Diagnostic Assay – hGH – Product Description 40

Accre Diagnostic Assay – PTH – Product Status 40

Accre Diagnostic Assay – PTH – Product Description 41

Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview 42

Immunodiagnostic Assay – Hormones – Product Status 42

Immunodiagnostic Assay – Hormones – Product Description 42

I-Mab Biopharma Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 43

Eftansomatropin Alfa TJ101 Companion Diagnostic Assay – Product Status 43

Eftansomatropin Alfa TJ101 Companion Diagnostic Assay – Product Description 43

Intelligent Bio Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 44

Diagnostic Test – Adrenal Disorders – Product Status 44

Diagnostic Test – Adrenal Disorders – Product Description 44

Diagnostic Test – Andrology Disorders – Product Status 45

Diagnostic Test – Andrology Disorders – Product Description 45

Diagnostic Test – Gynecological Disorders – Product Status 45

Diagnostic Test – Gynecological Disorders – Product Description 46

Diagnostic Test – Pituitary Disorders – Product Status 46

Diagnostic Test – Pituitary Disorders – Product Description 46

Diagnostic Test – Thyroid Disorders – Product Status 47

Diagnostic Test – Thyroid Disorders – Product Description 47

Laboratoire HRA Pharma SAS Pipeline Products & Ongoing Clinical Trials Overview 48

Indigo – Product Status 48

Indigo – Product Description 48

MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 49

Mitomic Test – Endocrinology – Product Status 49

Mitomic Test – Endocrinology – Product Description 49

MyHealthTest Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

Diagnostic Test – Hormones – Product Status 50

Diagnostic Test – Hormones – Product Description 50

Revvity Inc Pipeline Products & Ongoing Clinical Trials Overview 51

Accentis – Endocrine Disorders – Product Status 51

Accentis – Endocrine Disorders – Product Description 51

Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

Cobas 8000 Analyzer Series With c 502 Module – IGF BP3 Assay – Product Status 52

Cobas 8000 Analyzer Series With c 502 Module – IGF BP3 Assay – Product Description 53

Cobas 8000 Analyzer Series With c 502 Module – IGF-1 Assay – Product Status 53

Cobas 8000 Analyzer Series With c 502 Module – IGF-1 Assay – Product Description 53

Cobas 8000 Analyzer Series With c 701 Module – IGF BP3 Assay – Product Status 54

Cobas 8000 Analyzer Series With c 701 Module – IGF BP3 Assay – Product Description 54

Cobas 8000 Analyzer Series With c 701 Module – IGF-1 – Product Status 54

Cobas 8000 Analyzer Series With c 701 Module – IGF-1 – Product Description 55

Cobas 8000 Analyzer Series With c 702 Module – IGF-1 Assay – Product Status 55

Cobas 8000 Analyzer Series With c 702 Module – IGF-1 Assay – Product Description 55

Cobas PIGF Assay – Product Status 56

Cobas PIGF Assay – Product Description 56

Cobas sFlt-1 Assay – Product Status 56

Cobas sFlt-1 Assay – Product Description 57

IGF BP3 Assay – Product Status 57

IGF BP3 Assay – Product Description 57

IGF-1 Assay – Product Status 58

IGF-1 Assay – Product Description 58

Sendera Discovery Pipeline Products & Ongoing Clinical Trials Overview 59

Diagnostic Test Kit – Androgen Replacement Therapy – Product Status 59

Diagnostic Test Kit – Androgen Replacement Therapy – Product Description 59

Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

CL-1000i – Calcitonin Test – Product Status 60

CL-1000i – Calcitonin Test – Product Description 60

CL-1000i – Intact PTH Test – Product Status 61

CL-1000i – Intact PTH Test – Product Description 61

CL-1000i – Vitamin D Total Test – Product Status 61

CL-1000i – Vitamin D Total Test – Product Description 62

CL-2000i – hGH Test – Product Status 62

CL-2000i – hGH Test – Product Description 62

CL-2000i – IGF-1 Test – Product Status 63

CL-2000i – IGF-1 Test – Product Description 63

Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 64

ADVIA Centaur CP Immunoassay System – Growth Hormone – Product Status 65

ADVIA Centaur CP Immunoassay System – Growth Hormone – Product Description 65

ADVIA Centaur CP Immunoassay System – IGF-I – Product Status 65

ADVIA Centaur CP Immunoassay System – IGF-I – Product Description 66

ADVIA Centaur CP Immunoassay System – IGFBP-3 – Product Status 66

ADVIA Centaur CP Immunoassay System – IGFBP-3 – Product Description 66

ADVIA Centaur XP Immunoassay System – ACTH – Product Status 67

ADVIA Centaur XP Immunoassay System – ACTH – Product Description 67

ADVIA Centaur XP Immunoassay System – Growth Hormone – Product Status 67

ADVIA Centaur XP Immunoassay System – Growth Hormone – Product Description 68

ADVIA Centaur XP Immunoassay System – IGFBP-3 – Product Status 68

ADVIA Centaur XP Immunoassay System – IGFBP-3 – Product Description 68

ADVIA Centaur XP System – IGF-I Assay – Product Status 69

ADVIA Centaur XP System – IGF-I Assay – Product Description 69

ADVIA Centaur XPT Immunoassay System – ACTH – Product Status 69

ADVIA Centaur XPT Immunoassay System – ACTH – Product Description 70

ADVIA Centaur XPT Immunoassay System – IGFBP-3 – Product Status 70

ADVIA Centaur XPT Immunoassay System – IGFBP-3 – Product Description 70

ADVIA Centaur XPT System – Growth Hormone – Product Status 71

ADVIA Centaur XPT System – Growth Hormone – Product Description 71

ADVIA PIGF Assay – Product Status 71

ADVIA PIGF Assay – Product Description 72

ADVIA sFLT-1 Assay – Product Status 72

ADVIA sFLT-1 Assay – Product Description 72

Atellica IM Analyzer – ACTH Assay – Product Status 73

Atellica IM Analyzer – ACTH Assay – Product Description 73

Atellica IM Analyzer – hGH Assay – Product Status 74

Atellica IM Analyzer – hGH Assay – Product Description 74

Atellica IM Analyzer – IGF-I Assay – Product Status 75

Atellica IM Analyzer – IGF-I Assay – Product Description 75

Atellica IM Analyzer – IGFBP-3 Assay – Product Status 76

Atellica IM Analyzer – IGFBP-3 Assay – Product Description 76

Dimension Vista 1500 Intelligent Lab System – Loci Vitamin D Assay – Product Status 76

Dimension Vista 1500 Intelligent Lab System – Loci Vitamin D Assay – Product Description 77

Dimension Vista Cortisol Assay – Product Status 77

Dimension Vista Cortisol Assay – Product Description 77

Solvd Health Pipeline Products & Ongoing Clinical Trials Overview 78

Endocrinology Diagnostic Screening Test – Product Status 78

Endocrinology Diagnostic Screening Test – Product Description 78

Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 79

Cascadion SM Clinical Analyzer – Endocrinology – Product Status 79

Cascadion SM Clinical Analyzer – Endocrinology – Product Description 79

Tosoh Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 80

AIA-360 – Vitamin D Test – Product Status 80

AIA-360 – Vitamin D Test – Product Description 80

University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 81

Androgen Assay – Product Status 81

Androgen Assay – Product Description 81

Glossary 100

Figures

Endocrinology Tests – Pipeline Products by Stage of Development 11

Endocrinology Tests – Pipeline Products by Segment 12

Endocrinology Tests – Pipeline Products by Territory 13

Endocrinology Tests – Pipeline Products by Regulatory Path 14

Endocrinology Tests – Pipeline Products by Estimated Approval Date 15

Frequently asked questions

Endocrinology Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Endocrinology Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Endocrinology Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Endocrinology Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.